| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $60.8M | -8.3% |
| Cost of Revenue | $43.6M | -11.5% |
| Gross Profit | $17.2M | +0.8% |
| R&D Expense | $4.9M | +0.5% |
| SG&A Expense | $18.9M | +7.4% |
| Operating Income | -$6.6M | -22.3% |
| Income Tax | $3K | +50.0% |
| Net Income | -$8.3M | -23.6% |
| EPS (Basic) | -$0.50 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $643K | -73.0% |
| Accounts Receivable | $9.8M | +13.0% |
| Inventory | $17.0M | -10.6% |
| Current Assets | $28.3M | -8.4% |
| Total Assets | $32.3M | -9.5% |
| Current Liabilities | $30.7M | +28.7% |
| Total Liabilities | $32.1M | +22.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +79.9% |
| Capital Expenditures | $853K | -17.3% |
| Investing Cash Flow | -$853K | +16.7% |
| Financing Cash Flow | $3.9M | -39.7% |
| Free Cash Flow | -$5.7M | +77.3% |
| -19.0% |
| EPS (Diluted) | -$0.50 | -19.0% |
| Stockholders' Equity |
| $194K |
| -98.0% |